Reddy-Cheminor Inc. v. Canada (Attorney General) et al., (2003) 233 F.T.R. 271 (TD)
Linked as:
Extract
Reddy-Cheminor Inc. v. Canada (Attorney General) et al., (2003) 233 F.T.R. 271 (TD)
No longer available (Autolink)
See the full content of this document
This document cites
- Apotex Inc. v. Canada (Attorney General) et al., (1993) 59 F.T.R. 85 (TD)
- Merck Frosst Canada & Co. et al. v. Canada (Minister of Health) et al., (2000) 185 F.T.R. 267 (TD)
- Wrigley Can. v. Can., (2000) 256 N.R. 387 (FCA)
- Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2002) 224 F.T.R. 236 (TD)
- Conseil de la magistrature (N.-B.) v. Moreau-Bérubé, (2002) 245 N.B.R.(2d) 201 (SCC)
